Our researchers picked cells from all over the human body — cells of all shapes, sizes and abilities. From the brain to the heart to the intestines.
Stanford Medicine’s Sean Quirin once looked upward with a telescope, seeking clues to the universe. Now he trains his optical eye inward with a fascination for understanding the brain and the complex maladies that afflict it.
A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.
Often misunderstood and undertreated, bipolar disorder has received close attention from Stanford Medicine clinicians and researchers for more than 30 years.
A Q&A with a Stanford neuroscientist on dementia, healthy aging and memory loss — and how we can protect our brains in later life.
Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.
For Kaitlyn McCaffery, a brain injury survivor, finding community was the key to lifting her spirits during recovery.
Stanford Medicine headache fellow Sheena Pillai explains what doctors know about migraine attacks and describes treatment options.
Researchers developed a novel way to image inflammation in multiple sclerosis, a disease that is notoriously difficult to diagnose early.
Researchers at Stanford Medicine explore a potentially causative connection between a blood disorder and Alzheimer's.
Stanford Medicine scientists and collaborators discover a treatment in mice to repair the blood-brain barrier, which is key to brain health.
Stanford Medicine researcher Josef Parvizi explores the neural origins of where one's sense of self lives in the brain.
People with binge eating disorders have differences in their brains’ habit circuitry, which may explain why these behaviors are so persistent.
Stanford Medicine neurodiversity and autism expert Lawrence Fung discusses what it means to be neurodiverse in medicine.
A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.
A foam cap that fits over football helmets seemed to reduce the force of blows in lab experiments — but not on the field.
